Composition
- Active ingredients
- ETODOLAC 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- ETODOLAC 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletThis page
- ETODOLAC 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA018922-002 · Discontinued
- ETODOLAC 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA018922-005 · Discontinued
- ETODOLAC 300MG · CapsuleNDA018922-003 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA018922.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Lodine
- Active substance
- etodolac
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Wyeth Pharms Inc
- Status
- Discontinued
- FDA approval
- 31 Jan 1991
- Application
- NDA018922-004



